Abstract
Our previous studies have shown that treatment of MCF-7 breast cancer cells with cytokine oncostatin M (OM) results in a growth arrest and a concurrent decrease in p53 expression. It remains to be determined whether these two important events are directly connected, as changes in p53 protein levels can lead to variable biological outcomes. In this study we have generated stable cell lines (MCF7-ptsp53) that express p53Val135 a p53 temperature-sensitive mutant. We demonstrate that overexpression of the wildtype (wt) p53 at permissive temperature in MCF7-ptsp53 cells leads to growth arrest at the G2–M phase of the cell cycle. Inhibition of endogenous p53 function with the expression of mutant p53 protein at non-permissive temperature did not affect the OM-induced G1 cell cycle arrest. Microarray studies were further carried out to identify p53- and OM-regulated genes that mediate the G2/M or G1 cell cycle arrest. We show that the expression of p21 was upregulated and expressions of cdc2, cyclin B2 and protein regulator of cytokinesis 1 (PRC1) were suppressed by overexpression of the wt p53 in MCF7-ptsp53 cells at the permissive temperature. In contrast, OM treatment caused coordinate changes of mRNA expression of several cell cycle components including c/EBPδ, cdc20, and thymidine kinase 1 (TK1) that mainly affect G1–S phase transition. All together, our results suggest that the downregulation of p53 transcription may be involved in some other cellular changes induced by OM but it is not directly connected to the antiproliferative activity of OM per se.
Similar content being viewed by others
References
Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lionbin MN, Todaro GJ: Oncostatin M: a growth regulator produced by differentiated lymphoma cells. Proc Natl Acad Sci USA 83: 9739-9743, 1986
Liu J, Spence MJ, Wallace PM, Forcier K, Hellstrom I, Vestal RE: Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene. Cell Growth Diff 8: 667-676, 1997
Spence MJ, Vestal RE, Liu J: Oncostatin M-mediated transcriptional suppression of the c-myc gene in breast cancer cells. Cancer Res 57: 2223-2228, 1997
Douglas AM, Grant SL, Goss GA, Clouston DR, Sutherland RL, Begley CG: Oatncostatin M induces the differentiation of breast cancer cells. Int J Cancer 75: 64-73, 1998
Harris CC: Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88: 1442-1455, 1996
Liu J, Ahlborn TE, Li C, Spence MJ, Boxer LM: Transcription of tumor suppressor p53 gene is down-regulated in differentiated breast cancer cells induced by cytokine oncostatin M and PMA. Cell Growth Diff 10: 677-683, 1999
Li C, Ahlborn TE, Tokita K, Boxer L, Noda A, Liu J: The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells. Oncogene 20: 8193-8202, 2001
Michalovitz D, Halevy O, Oren M: Conditional inhibition of transformation and of cell proliferation by a temperaturesensitive mutant p53. Cell 62: 671-680, 1990
Milner J, Medcalf E: Temperature-dependent switching between "wild-type" and "mutant" forms of p53Val135. J Mol Biol 210: 481-484, 1990
Martinez J, Georgoff I, Levine AJ: Cellular location and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 5: 151-159, 1991
Hughes A, Gollapudi L, Sladek T, Neet K: Mediation of nerve growth factor-driven cell cycle arrest in PC12 cells by p53. J Biol Chem 275: 37829-37837, 2000
Liu X, Nishitani J, McQuirter JL, Baluda MA, Park NH: The temperature sensitive mutant p53-143ala extends in vitro life span, promotes errors in DNA replication and impairs DNA repair in normal human oral kerakinocytes. Cell Mol Biol 47: 1169-1178, 2001
Eliyahu D, Evans S, Rosen N, Eliyahu S, Zwiebel J, Paik S, Lippman M: p53Val135 temperature sensitive mutant suppresses growth of human breast cancer cells. Breast Cancer Res Treatment 30: 167-177, 1994
Pollock R, Lang A, Ge T, Sun D, Tan M, Yu D: Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control. Clinical Cancer Res 4: 1985-1994, 1998
Willers H, McCarthy E, Wu B, Wunsch H, Tang W, Taghian D, Xia F, Powell SN: Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control. Oncogene 19: 632-639, 2000
Agarwal M, Agarwal A, Taylor W, Stark GR: p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92: 8493-8497, 1995
Taylor W, DePrimo S, Agarwal A, Agarwal M, Schönthal A, Katula K, Stark G: Mechanisms of G2 arrest in response to overexpression of p53. Mol Biol Cell 10: 3607-3622, 1999
Wang F: Analysis of downstream effectors of p53 on cell growth arrest and apoptosis induced by a temperaturesensitive Val138 mutant. J Med Dent Sci 45: 141-149, 1998
Chylicki K, Ehinger M, Svedberg H, Gullberg U: Characterization of the molecular mechanisms for p53-mediated differentiation. Cell Growth Diff 11: 561-571, 2000
Sugrue MM, Shin DY, Lee SW, Aaronson SA: Wildtype p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sci USA 94: 9648-9653, 1997
Dubrez L, Coll J, Hurbin A, Fraipont F, Lantejoul S, Favrot M: Cell cycle arrest is sufficient for p53-mediated tumor regression. Gene Therapy 8: 1705-1712, 2001
Tang H, Zhao K, Pizzolato JF, Fonarev M, Langer JC, Manfredi JJ: Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53. J Biol Chem 273: 29156-29163, 1998
Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Browm J, Sedivy J, Kinzler K, Vogelstein B: Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501, 1998
Bargonetti J, Manfredi J: Multiple roles of the tumor suppressor p53. Curr Opin Oncol 14: 86-91, 2002
Chan TA, Hwang PM, Hermeking H, Kinzler KW, Vogelstein B: Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev 14: 1584-1588, 2000
Gautier J, Minshull J, Lohka M, Glotzer M, Hunt T, Maller JL: Cyclin is a component of maturation-promoting factor from Xenopus. Cell 60: 487-494, 1990
Kruse K, Wasner M, Reinhard W, Ulrike H, Dohna C, Mössner J, Engeland K: The tumor suppressor protein p53 can repress transcription of cyclin B. Nucl Acids Res 28: 4410-4418, 2000
Jiang W, Jimenez G, Wells N, Hope T, Wahl G, Hunter T, Fukunaga R: PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis. Mol Cell 2: 877-885, 1998
Liu J, Hadjokas N, Mosley B, Estrov Z, Spence MJ, Vestal RE: Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells. Cytokine 10: 295-302, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Li, C., Shridhar, K. & Liu, J. Molecular Characterization of Oncostatin M-induced Growth Arrest of MCF-7 Cells Expressing a Temperature-Sensitive Mutant of p53. Breast Cancer Res Treat 80, 23–37 (2003). https://doi.org/10.1023/A:1024483017549
Issue Date:
DOI: https://doi.org/10.1023/A:1024483017549